FindTrial
Sign In

cis Platinum/carboplatin

DRUG2 trials

Sponsors

Zhongnan Hospital, The First Affiliated Hospital with Nanjing Medical University

Conditions

AngiogenesisChemoradiotherapyTo Evaluate the Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical CancerUterine Cervical Neoplasms

Phase 2

Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer
NCT05772377
The First Affiliated Hospital with Nanjing Medical UniversityTo Evaluate the Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer
Start: 2023-07-01End: 2025-06-01Target: 36Updated: 2023-03-16

Unknown Phase

Concurrent Radiochemotherapy Plus Anlotinib for Locally Advanced Cervical Cancer
RecruitingNCT04772001
Zhongnan HospitalAngiogenesis, Chemoradiotherapy, Uterine Cervical Neoplasms
Start: 2021-03-12End: 2026-01-31Target: 53Updated: 2022-05-18